Protein disulfide isomerase A3 as novel biomarker for endometrial cancer

OBJECTIVE: This study aims to investigate the potential of PDIA3 as a novel prognostic biomarker and therapeutic target for Endometrial Cancer (EC) with the ultimate goal of improving survival rates in EC patients. METHODS: This study employed a combination of public database analysis and clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Fanrong, Liu, Xin, Li, Min, Liu, Xiufen, Wang, Xintai, Guo, Meixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614013/
https://www.ncbi.nlm.nih.gov/pubmed/37909009
http://dx.doi.org/10.3389/fonc.2023.1247446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614013/
https://www.ncbi.nlm.nih.gov/pubmed/37909009
http://dx.doi.org/10.3389/fonc.2023.1247446

Ejemplares similares